Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Open Label Study to Evaluate the Effect of Avastin in Association With Chemotherapy on Progression-Free Survival in Patients With Progressive Advanced/Metastatic Well-Differentiated Digestive Endocrine Tumors of the Gastrointestinal Tract.

Trial Profile

An Open Label Study to Evaluate the Effect of Avastin in Association With Chemotherapy on Progression-Free Survival in Patients With Progressive Advanced/Metastatic Well-Differentiated Digestive Endocrine Tumors of the Gastrointestinal Tract.

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Jan 2015

At a glance

  • Drugs Bevacizumab (Primary) ; Capecitabine; Fluorouracil; Streptozocin
  • Indications Gastrointestinal cancer; Pancreatic cancer
  • Focus Therapeutic Use
  • Acronyms BETTER
  • Sponsors Roche
  • Most Recent Events

    • 17 Jan 2012 Planned end date changed from 1 Apr 2012 to 1 May 2012 as reported by ClinicalTrials.gov.
    • 15 Oct 2010 Planned end date changed from 1 Oct 2011 to 1 Apr 2012 as reported by ClinicalTrials.gov.
    • 18 Nov 2009 Status changed from recruiting to active, no longer recruiting as reported by Roche record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top